Cite
HARVARD Citation
Yamamoto, Y. et al. (n.d.). Impact of CYP2C19 Phenotypes on Clinical Efficacy of Stiripentol in Japanese Patients With Dravet Syndrome. Therapeutic drug monitoring. 42 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamamoto, Y. et al. (n.d.). Impact of CYP2C19 Phenotypes on Clinical Efficacy of Stiripentol in Japanese Patients With Dravet Syndrome. Therapeutic drug monitoring. 42 (2), p. . [Online].